NIBRT National Institute for Bioprocessing Research and Training

We are incredibly proud of Prof. Liz Topp, one of NIBRT’s PIs, who is leading the charge in pharmaceutical manufacturing innovation as Director of the Young Institute Pharmaceutical Manufacturing Consortium at Purdue University.   Working alongside Eli Lilly and Merck & Co., Liz and her team are tackling some of the biggest challenges in biopharma—from mRNA stability to advanced aseptic processing—helping to shape the future of how medicines are made.   Read more about Liz’s work and this exciting initiative, here: https://lnkd.in/eg_BBq_n   Liz is a fantastic scientist, leader, and collaborator, and we’re so lucky to have her as part of the NIBRT research community.

NIBRT are excited to announce the signing of a Memorandum of Understanding with Dún Laoghaire Institute of Art, Design and Technology. The signing of the MOU represents a significant step forward in strengthening interdisciplinary ties between IADT, known for its leadership in the creative industries, and NIBRT, a global leader in biopharmaceutical manufacturing training and research. We look forward to this partnership with a focus on innovative collaboration, leveraging the expertise and unique strengths of both institutions. Read the full press release here: https://lnkd.in/eKWaaCCV

As part of our International Women’s Day celebrations, we were delighted to welcome Dr Juliana Dias Alves Pinto, Head of CAR-T Manufacturing at UCL to NIBRT today. Juliana is a visionary leader in her field and she delivered an inspiring seminar entitled ‘From Bench to Clinic: Academic CAR-T Development and Manufacturing at UCL’. Juliana also met with the research and CONCEPT team for engaging discussions about the future for advanced therapies here in Ireland. Pictured with Juliana are Julia Serna and Fiona Killard-Lynch

Join Us at the NIBRT Research Conference 2025.   NIBRT is bringing together leading voices from academia, industry, healthcare, and policy to explore Ireland’s Role in Europe’s Biotech Future. Expect insightful talks, dynamic discussions, and unparalleled networking with global biotech and biopharma experts. https://lnkd.in/ek6kGCT2   15th - 16th of April, NIBRT, Dublin   Register your interest now – places are limited. https://lnkd.in/erM-7sy4

Brian Philip and Julia Serna from our CONCEPT team are attending the Advanced Therapies conference in London this week. Yesterday, Brian gave a talk entitled ‘Leveraging platform technology to interrogate immunotherapy’ and moderated a panel discussion about technological innovations in cell therapy manufacturing. The team also have a poster about our CONCEPT facility, so stop by if you are at the conference! #adtherapies

Fastnet are delighted to partner with NIBRT National Institute for Bioprocessing Research and Training to hire a Director of Technology and Data. This role will establish and lead the Director of Technology & Data function, shaping and refining its focus on operations, technology, data, and innovation—both internally and externally. As a key member of the Site Leadership team, you will play a crucial role in driving the organisation toward its strategic goals and objectives. Please reach out to Jill Madden for a confidential conversation - jill@fastnettalent.com

Advance Your Data Analytics Skills in Biopharma - Short Course 08 - 10 April 2025 Our Advanced Data Analytics course is a three-day onsite programme designed for those who have completed the Introduction to Data Analytics for Biopharma Manufacturing and want to develop their expertise further. Taking place from 8–10 April at NIBRT, this course provides advanced skills and knowledge essential for data analytics in biopharma manufacturing. Key topics include: -Reproducibility in Data Science – Infrastructure, documentation, and version control (Git) -Linear and Non-Linear Regression – Combining bioprocess knowledge with statistical modelling -Design of Experiments (DoE) – Benefits over one-factor-at-a-time (OFAT) experiments -Statistical Process Control (SPC) – Control charts and process capability -Ideal for those with a good foundation in statistics, including process and quality control scientists Enrol now https://hubs.la/Q03bsK_10

Starts Tomorrow – Register Now for the PQS & RBDM Webinar - 'Demonstrating the Effectiveness of the PQS and the Role of Risk-Based Decision Making' This is a reminder that our free webinar takes place tomorrow. Last chance to register! Date: 13 March 2025 Time: 3:00 PM Dublin/GMT Join NIBRT and PRST at TU Dublin for a valuable session on: Risk-Based Decision Making (RBDM) and PQS effectiveness Updates from ICH Q9(R1) Practical insights into Quality Risk Management (QRM) Speakers: Valerie Mulholland: Principal Consultant, GMP Services Michael Schousboe: Senior QMS Specialist in Quality Risk Management, Novo Nordisk Professor Kevin O’Donnell: Market Compliance Manager, Health Products Regulatory Authority (HPRA) Moderator: Alice Redmond: Chief Strategy Officer (CSO), CAI Register: https://hubs.la/Q0382n7q0

Prof. Mark Smales Secures Prestigious Taighde Éireann Award to Advance Biotherapeutics Manufacturing NIBRT is pleased to announce Prof. Mark Smales has been awarded over €3.5 million through the prestigious Taighde Éireann - Research Ireland Research Professorship Programme. Holding a joint appointment between NIBRT and the University of Kent, Prof. Smales will lead a five-year research programme focused on revolutionising the manufacturing of next generation biotherapeutics. The project will be based at NIBRT and will support a dedicated research team, including three PhD studentships. Biotherapeutics, such as monoclonal antibodies, gene therapies, and RNA-based medicines, have transformed the treatment of diseases worldwide. Manufacturing these advanced therapies, however, remains complex, inefficient, and costly, limiting their availability and impact. Prof. Smales’ research will take a pioneering approach to redefine how these medicines are produced, making manufacturing more efficient, predictable, and scalable. The project will focus on three key areas: Gene Therapy Production – Understanding the biology of the cells and genetic components that underpin gene therapy manufacturing and developing improved production systems. RNA Therapeutics – Investigating how RNA sequences, modifications, and control elements impact their effectiveness as vaccines and therapeutics. Bioprocess Engineering – Applying cutting-edge engineering biology techniques to create new cell factories capable of producing novel format, complex biotherapeutic proteins with improved quality and yield. Read full press release here https://hubs.la/Q03b2PjX0

NIBRT Careers in Biopharma 2025 is fast approaching, and we are delighted to share the list of top biopharma companies ready to meet YOU! Whether you're looking to kick-start your career or explore new opportunities in the industry, this is your chance to connect with leading employers. Exhibitors include: AbbVie, Amgen, APC Ltd & VLE Therapeutics, Arcadis, Astellas, ATU, BioMarin, BMS, Eurofins, Fastnet, Grifols, Johnson & Johnson Innovative Medicine, KPC International, LSC, MSD, NIBRT, Parker Hannifin Ltd, PDA Ireland, Pfizer, RCSI, Sanofi, TU Dublin, Veolia, WuXi Biologics. Exhibitor enquiries: Interested in exhibiting? Contact emer.norton@nibrt.ie In its 11th year, NIBRT Careers in Biopharma is Ireland’s largest biopharma careers fair, bringing together graduates and top employers in the biopharma industry. When: Saturday, 29th March 2025, 10:00 AM – 3:30 PM Where: O'Reilly Hall, University College Dublin, Belfield, Dublin 4 Cost: Free (registration required) Why attend? Meet top biopharma employers actively hiring Gain industry insights from expert talks Discover training programmes and upskilling opportunities Network with industry professionals Register now: Attendance is free, but advance registration is required (limited places). https://hubs.la/Q039V4sf0 #Biopharma #CareerFair #NIBRT